Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Anbio Biotechnology before investing.

In this article, we go over a few key elements for understanding Anbio Biotechnology’s stock price such as:

• Anbio Biotechnology’s current stock price and volume
• Why Anbio Biotechnology’s stock price changed recently
• Upgrades and downgrades for NNNN from analysts
• NNNN’s stock price momentum as measured by its relative strength

About Anbio Biotechnology (NNNN)

Before we jump into Anbio Biotechnology’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Want to learn more about Anbio Biotechnology’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Anbio Biotechnology.

Anbio Biotechnology’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Anbio Biotechnology’s stock price was $9.900.

Anbio Biotechnology is down 7.91% from its previous closing price of $10.750.

During the last market session, Anbio Biotechnology’s stock traded between $9.000 and $10.600. Currently, there are approximately 43.89 million shares outstanding for Anbio Biotechnology.

Anbio Biotechnology’s price-earnings (P/E) ratio is currently at 68.9, which is high compared to the Biotechnology industry median of 19. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Anbio Biotechnology Stock Price History

Anbio Biotechnology’s (NNNN) price is currently down 27.79% so far this month.

During the month of July, Anbio Biotechnology’s stock price has reached a high of $13.690 and a low of $8.300.

Over the last year, Anbio Biotechnology has hit prices as high as $54.950 and as low as $8.300. Year to date, Anbio Biotechnology’s stock is down 67.08%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Anbio Biotechnology Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Anbio Biotechnology’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Anbio Biotechnology’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Anbio Biotechnology’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Anbio Biotechnology’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Anbio Biotechnology (NNNN) by visiting AAII Stock Evaluator.

Relative Price Strength of Anbio Biotechnology

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Anbio Biotechnology has a weighted four-quarter relative price strength of -32.10%, which translates to a Momentum Score of 6 and is considered to be Very Weak.

Want to learn more about how Anbio Biotechnology is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Anbio Biotechnology Stock Price: Bottom Line

As of July 31, 2026, Anbio Biotechnology’s stock price is $9.900, which is down 7.91% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Anbio Biotechnology stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.